DiaccurateSolid financial experience for DiaccurateLaurence Riot Lamotte has started at the beginning of 2022 als new Chief Financial Officer of French Diaccurate. She succeeds José Da Gloria, who left the company. more ➔
New CEO for Galapagos Co-founder and former board member of Galapagos NV Dr Paul Stoffels will take over the position of Chief Executive Officer at the Belgian company from April. He succeeds long-time CEO Onno van de Stolpe, … more ➔
Immunovia with acting CEOImmunovia AB announces that Philipp Mathieu has been appointed as acting CEO and President with immediate effect. The search for a permanent CEO continues, as previously communicated. more ➔
Onxeo with interim CEO Paris-based Onxeo S.A. has started the new year with an interim CEO. Julien Miara has taken over the position. more ➔
Successor wanted Gabriella Björknert Caracciolo will leave Bactiguard AB, where she currently works as CFO and deputy CEO. more ➔
Back as CEO Swedish Oncopeptides has had a new CEO since mid-November. Jakob Lindberg has taken over the position from Marty J. Duvall again. He has left the company. more ➔
Immunovia in search of a new CEO Lund-based Immunovia will need a new CEO, because Patrik Dahlen wants to leave the diagnostics company for personal reasons. more ➔
Genoskin appointed CSO Dr Nicolas Gaudenzio has been started at the beginning of November as Chief Scientific Officer of Genoskin. more ➔
From interim to permanent Lotta Ferm, interim CFO of Immunicum AB, was now named as Chief Financial Officer. more ➔
BIAL with new R&D General Manager BIAL, a public limited company under Portuguese law with head office in Coronado, Portugal, appointed Joerg Holenz as R&D General Manager and as a member of the Board of Directors. more ➔
